Skip to content

Effects of Light Emitting Diode Irradiation on the Conduction Parameters of the Superficial Radial Nerve

The Effect of Light Therapy on Superficial Radial Nerve Conduction Using a Clustered Array of Infrared Super Luminous and Red Light Emitting Diodes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01513148
Enrollment
32
Registered
2012-01-20
Start date
2006-06-30
Completion date
2008-09-30
Last updated
2013-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Neuropathy

Brief summary

The introduction of light emitting diode (LED) devices as a novel treatment for pain relief in place of low-level laser warrants fundamental research on the effect of LED devices on one of the potential explanatory mechanisms: peripheral neurophysiology in vivo. A randomized controlled study will be conducted by measuring nerve conduction on the superficial radial nerve of healthy subjects (n=64). One baseline measurement and five post-irradiation recordings (2-min interval each) will be performed of the nerve conduction velocity (NCV) and peak latency (PL) and peak amplitude (PA). The experimental group (=32) will receive an irradiation of 2 J/cm2 with an infrared LED device (Dynatronics Solaris Model 705), while the placebo group will be treated by sham irradiation. The purpose of this study is to investigate the effects of LED light on the conduction velocity and amplitude of the superficial radial nerve.

Interventions

DEVICESuperluminous light diode

900W, 880nm, 1.6 J/cm2 for 30sec

Sponsors

Shenandoah University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* no history of neurological disease, polyneuropathy, peripheral neuropathy or cervical radiculopathy

Exclusion criteria

* positive findings during the clinical screening examination suggestive of an underlying neurological disease, polyneuropathy, peripheral neuropathy or cervical radiculopathy. * a history of a neurological disease, polyneuropathy, peripheral neuropathy or cervical radiculopathy.

Design outcomes

Primary

MeasureTime frameDescription
Nerve Conduction Velocity (Meters Per Second)pre-treatment, 0 min, 2 min, 4 min, 6 min, 8 min and 10 min after treatmentChange in nerve conduction velocity (m/s) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs. Calculated difference scores at each time point = nerve conduction velocity (NCV) - baseline NCV. A positive variance represented an increase from baseline and is interpreted as being an increase or faster velocity.

Secondary

MeasureTime frameDescription
Negative Peak Latency (Milliseconds)pre-treatment, 0 min, 2 min, 4 min, 6 min, 8 min and 10 min after treatmentChange in negative peak latency (ms) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs. Calculated difference scores at each time period = negative peak latency NPL - baseline NPL. A positive variance can be interpreted as being increase from baseline or a prolonged or slowed NPL.
Temperature (Degrees C)pre-treatment, 0 min, 2 min, 4 min, 6 min, 8 min and 10 min after treatmentChange in superficial skin temperature (degrees C) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs. Calculated difference scores at each time point = Temperature - Temperature at baseline. A positive variance int his calculation can be interpreted as being an increase from baseline or an increase in skin temperature

Countries

United States

Participant flow

Participants by arm

ArmCount
Light Therapy
Application of super luminous diodes light irradiation over the superficial radial nerve
16
Sham Irradiation
Sham Irradiation over the Superficial Radial Nerve for the same time period as the intervention group
16
Total32

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation22

Baseline characteristics

CharacteristicSham IrradiationLight TherapyTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
16 Participants16 Participants32 Participants
Age Continuous25.5 years
STANDARD_DEVIATION 3.9
24.5 years
STANDARD_DEVIATION 2.1
24.7 years
STANDARD_DEVIATION 3.2
Region of Enrollment
United States
16 participants16 participants32 participants
Sex: Female, Male
Female
13 Participants12 Participants25 Participants
Sex: Female, Male
Male
3 Participants4 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 16
serious
Total, serious adverse events
0 / 160 / 16

Outcome results

Primary

Nerve Conduction Velocity (Meters Per Second)

Change in nerve conduction velocity (m/s) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs. Calculated difference scores at each time point = nerve conduction velocity (NCV) - baseline NCV. A positive variance represented an increase from baseline and is interpreted as being an increase or faster velocity.

Time frame: pre-treatment, 0 min, 2 min, 4 min, 6 min, 8 min and 10 min after treatment

ArmMeasureValue (MEAN)Dispersion
Light NCV PretreatmentNerve Conduction Velocity (Meters Per Second)0.000 m/sStandard Deviation 0
Light NCV Time 0Nerve Conduction Velocity (Meters Per Second)-0.358 m/sStandard Deviation 1.2
Light NCV Time 2Nerve Conduction Velocity (Meters Per Second)0.447 m/sStandard Deviation 1.616
Light NCV Time 4Nerve Conduction Velocity (Meters Per Second)0.147 m/sStandard Deviation 1.785
Light NCV Time 6Nerve Conduction Velocity (Meters Per Second)-0.041 m/sStandard Deviation 1.741
Light NCV Time 8Nerve Conduction Velocity (Meters Per Second)0.280 m/sStandard Deviation 1.801
Light NCV Time 10Nerve Conduction Velocity (Meters Per Second)0.100 m/sStandard Deviation 2.117
Sham NCV PretreatmentNerve Conduction Velocity (Meters Per Second)0.000 m/sStandard Deviation 0
Sham NCV Time 0Nerve Conduction Velocity (Meters Per Second)0.151 m/sStandard Deviation 1.251
Sham NCV Time 2Nerve Conduction Velocity (Meters Per Second)-0.004 m/sStandard Deviation 1.386
Sham NCV Time 4Nerve Conduction Velocity (Meters Per Second)0.447 m/sStandard Deviation 1.616
Sham NCV Time 6Nerve Conduction Velocity (Meters Per Second)1.116 m/sStandard Deviation 1.53
Sham NCV Time 8Nerve Conduction Velocity (Meters Per Second)0.521 m/sStandard Deviation 1.652
Sham NCV Time 10Nerve Conduction Velocity (Meters Per Second)0.675 m/sStandard Deviation 2.012
Secondary

Negative Peak Latency (Milliseconds)

Change in negative peak latency (ms) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs. Calculated difference scores at each time period = negative peak latency NPL - baseline NPL. A positive variance can be interpreted as being increase from baseline or a prolonged or slowed NPL.

Time frame: pre-treatment, 0 min, 2 min, 4 min, 6 min, 8 min and 10 min after treatment

ArmMeasureValue (MEAN)Dispersion
Light NCV PretreatmentNegative Peak Latency (Milliseconds)0.000 msStandard Deviation 0
Light NCV Time 0Negative Peak Latency (Milliseconds)0.414 msStandard Deviation 0.429
Light NCV Time 2Negative Peak Latency (Milliseconds)0.007 msStandard Deviation 0.07
Light NCV Time 4Negative Peak Latency (Milliseconds)-0.007 msStandard Deviation 0.08
Light NCV Time 6Negative Peak Latency (Milliseconds)0 msStandard Deviation 0.755
Light NCV Time 8Negative Peak Latency (Milliseconds)-0.014 msStandard Deviation 0.083
Light NCV Time 10Negative Peak Latency (Milliseconds)-0.007 msStandard Deviation 0.096
Sham NCV PretreatmentNegative Peak Latency (Milliseconds)-0.007 msStandard Deviation 0.059
Sham NCV Time 0Negative Peak Latency (Milliseconds)0.000 msStandard Deviation 0.065
Sham NCV Time 2Negative Peak Latency (Milliseconds)-0.021 msStandard Deviation 0.077
Sham NCV Time 4Negative Peak Latency (Milliseconds)-0.050 msStandard Deviation 0.073
Sham NCV Time 6Negative Peak Latency (Milliseconds)-0.021 msStandard Deviation 0.077
Sham NCV Time 8Negative Peak Latency (Milliseconds)-0.028 msStandard Deviation 0.096
Sham NCV Time 10Negative Peak Latency (Milliseconds)0 msStandard Deviation 0
Secondary

Temperature (Degrees C)

Change in superficial skin temperature (degrees C) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs. Calculated difference scores at each time point = Temperature - Temperature at baseline. A positive variance int his calculation can be interpreted as being an increase from baseline or an increase in skin temperature

Time frame: pre-treatment, 0 min, 2 min, 4 min, 6 min, 8 min and 10 min after treatment

ArmMeasureValue (MEAN)Dispersion
Light NCV PretreatmentTemperature (Degrees C)0.000 Degrees CelsiusStandard Deviation 0
Light NCV Time 0Temperature (Degrees C)0.414 Degrees CelsiusStandard Deviation 0.429
Light NCV Time 2Temperature (Degrees C)0.993 Degrees CelsiusStandard Deviation 0.626
Light NCV Time 4Temperature (Degrees C)0.686 Degrees CelsiusStandard Deviation 1.21
Light NCV Time 6Temperature (Degrees C)0.757 Degrees CelsiusStandard Deviation 1.336
Light NCV Time 8Temperature (Degrees C)0.786 Degrees CelsiusStandard Deviation 1.341
Light NCV Time 10Temperature (Degrees C)0.778 Degrees CelsiusStandard Deviation 1.432
Sham NCV PretreatmentTemperature (Degrees C)0.000 Degrees CelsiusStandard Deviation 0
Sham NCV Time 0Temperature (Degrees C)0.814 Degrees CelsiusStandard Deviation 0.662
Sham NCV Time 2Temperature (Degrees C)1.021 Degrees CelsiusStandard Deviation 0.591
Sham NCV Time 4Temperature (Degrees C)0.993 Degrees CelsiusStandard Deviation 0.626
Sham NCV Time 6Temperature (Degrees C)1.007 Degrees CelsiusStandard Deviation 0.796
Sham NCV Time 8Temperature (Degrees C)0.928 Degrees CelsiusStandard Deviation 0.82
Sham NCV Time 10Temperature (Degrees C)0.878 Degrees CelsiusStandard Deviation 0.847

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026